Case Report: Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Crohn’s Disease

Case Report: Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Crohn’s Disease

Chronic spontaneous urticaria (CSU) is a mast cell-driven disease that is often associated with autoimmune or autoinflammatory conditions. Omalizumab is recommended in the treatment of refractory CSU in patients over 12 years of age who do not respond to four standard doses of antihistamines. Omaliz...

Full description

Bibliographic Details
Main Authors: Simona Barni, Mattia Giovannini, Giulia Liccioli, Lucrezia Sarti, Anna Gissi, Paolo Lionetti, Francesca Mori
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Immunology
Subjects:
anti-IgE monoclonal antibody
chronic spontaneous urticaria
inflammatory bowel diseases
Crohn’s disease
omalizumab
adolescent
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.635069/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.635069/full

Similar Items